International Assets Investment Management, LLC Regeneron Pharmaceuticals, Inc. Transaction History
International Assets Investment Management, LLC
- $36.5 Billion
- Q3 2024
A detailed history of International Assets Investment Management, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, International Assets Investment Management, LLC holds 880,939 shares of REGN stock, worth $628 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
880,939
Previous 1,023
86013.29%
Holding current value
$628 Million
Previous $1.08 Billion
99.92%
% of portfolio
0.0%
Previous 0.1%
Shares
14 transactions
Others Institutions Holding REGN
# of Institutions
1,534Shares Held
83.6MCall Options Held
1.22MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.64 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.02 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.34 Billion0.64% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.49 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$3.06 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $76.4B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...